Mina Maftouh

2.4k total citations
39 papers, 1.9k citations indexed

About

Mina Maftouh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mina Maftouh has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Mina Maftouh's work include Pancreatic and Hepatic Oncology Research (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Liver physiology and pathology (6 papers). Mina Maftouh is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Liver physiology and pathology (6 papers). Mina Maftouh collaborates with scholars based in Iran, Netherlands and United Kingdom. Mina Maftouh's co-authors include Amir Avan, Seyed Mahdi Hassanian, Soodabeh Shahidsales, Afsane Bahrami, Majid Khazaei, Gordon A. Ferns, Majid Ghayour‐Mobarhan, Godefridus J. Peters, Elisa Giovannetti and Malihe Hasanzadeh and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Cancer.

In The Last Decade

Mina Maftouh

38 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mina Maftouh Iran 26 1.2k 752 648 204 197 39 1.9k
Longjuan Zhang China 27 1.4k 1.1× 860 1.1× 462 0.7× 246 1.2× 190 1.0× 55 2.0k
Leina Ma China 24 1.6k 1.3× 793 1.1× 536 0.8× 114 0.6× 186 0.9× 50 2.2k
Juanjuan Shan China 24 1.4k 1.2× 735 1.0× 635 1.0× 148 0.7× 208 1.1× 41 2.1k
Jiong Bi China 27 1.7k 1.4× 1.0k 1.4× 594 0.9× 169 0.8× 228 1.2× 51 2.5k
Ximing Xu China 24 896 0.7× 599 0.8× 527 0.8× 131 0.6× 198 1.0× 101 1.6k
Federica Papaccio Italy 21 1.0k 0.8× 594 0.8× 909 1.4× 105 0.5× 185 0.9× 42 2.0k
Keqiang Zhang China 29 1.2k 1.0× 682 0.9× 456 0.7× 153 0.8× 109 0.6× 75 1.9k
Limei Liu China 22 1.1k 0.9× 507 0.7× 565 0.9× 101 0.5× 182 0.9× 42 1.7k
Xian Lin China 23 1.2k 1.0× 637 0.8× 476 0.7× 99 0.5× 166 0.8× 63 1.7k

Countries citing papers authored by Mina Maftouh

Since Specialization
Citations

This map shows the geographic impact of Mina Maftouh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Maftouh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Maftouh more than expected).

Fields of papers citing papers by Mina Maftouh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Maftouh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Maftouh. The network helps show where Mina Maftouh may publish in the future.

Co-authorship network of co-authors of Mina Maftouh

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Maftouh. A scholar is included among the top collaborators of Mina Maftouh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Maftouh. Mina Maftouh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zafari, Nima, M.S. Fahim, Mina Maftouh, et al.. (2022). Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective. Life Sciences. 305. 120760–120760. 33 indexed citations
2.
Hassouni, Btissame El, Rocco Sciarrillo, Mina Maftouh, et al.. (2019). Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2. 3082–3082. 1 indexed citations
3.
Hassouni, Btissame El, Rocco Sciarrillo, Mina Maftouh, et al.. (2019). Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2. Cancer Research. 79(13_Supplement). 3082–3082.
4.
Massihnia, Daniela, Amir Avan, Niccola Funel, et al.. (2017). Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer. Journal of Hematology & Oncology. 10(1). 9–9. 69 indexed citations
5.
Bahrami, Afsane, Seyed Mahdi Hassanian, Soodabeh Shahidsales, et al.. (2017). Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. Journal of Cellular Physiology. 233(3). 2058–2066. 65 indexed citations
6.
Hosseini, Mina, Seyed Mahdi Hassanian, Soodabeh Shahidsales, et al.. (2017). Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives. Journal of Cellular Biochemistry. 118(7). 1634–1638. 31 indexed citations
7.
Shafiee, Mojtaba, et al.. (2017). Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer. Current Pharmaceutical Design. 23(13). 2002–2008. 20 indexed citations
8.
Bahrami, Afsane, Forouzan Amerizadeh, Soodabeh Shahidsales, et al.. (2017). Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress. Journal of Cellular Biochemistry. 118(8). 1979–1983. 126 indexed citations
9.
Ebrahimi, Safieh, Mina Hosseini, Faezeh Ghasemi, et al.. (2016). Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. Current Pharmaceutical Design. 22(42). 6444–6450. 30 indexed citations
10.
Tajbakhsh, Amir, Seyed Mahdi Hassanian, Alireza Pasdar, et al.. (2016). The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications. Current Pharmaceutical Design. 22(37). 5730–5737. 25 indexed citations
11.
Mirzaei, Hamed, Mina Maftouh, Mohsen Mohammadi, et al.. (2016). Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. Current Medicinal Chemistry. 23(36). 4135–4150. 109 indexed citations
12.
Hosseini, Mina, Seyed Mahdi Hassanian, Reza Nedaeinia, et al.. (2016). Exosome-Encapsulated microRNAs as Potential Circulating Biomarkers in Colon Cancer. Current Pharmaceutical Design. 23(11). 1705–1709. 86 indexed citations
13.
Avan, Abolfazl, Mina Maftouh, Niccola Funel, et al.. (2014). MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside. Current Medicinal Chemistry. 21(8). 975–989. 17 indexed citations
14.
Maftouh, Mina, Amir Avan, Niccola Funel, et al.. (2014). miR-211 Modulates Gemcitabine Activity Through Downregulation of Ribonucleotide Reductase and Inhibits the Invasive Behavior of Pancreatic Cancer Cells. Nucleosides Nucleotides & Nucleic Acids. 33(4-6). 384–393. 54 indexed citations
15.
Avan, Abolfazl, Amir Avan, Tessa Y. S. Le Large, et al.. (2014). AKT1 and SELP Polymorphisms Predict the Risk of Developing Cachexia in Pancreatic Cancer Patients. PLoS ONE. 9(9). e108057–e108057. 36 indexed citations
16.
Maftouh, Mina, Amir Avan, Niccola Funel, et al.. (2014). A Polymorphism in the promoter is Associated with EZH2 Expression but not with Outcome in Advanced Pancreatic Cancer Patients. Pharmacogenomics. 15(5). 609–618. 6 indexed citations
17.
18.
Maftouh, Mina, Abolfazl Avan, Rocco Sciarrillo, et al.. (2013). Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. British Journal of Cancer. 110(1). 172–182. 142 indexed citations
19.
Maftouh, Mina, Amir Avan, Elena Galvani, Godefridus J. Peters, & Elisa Giovannetti. (2013). Molecular Mechanisms Underlying the Role of MicroRNAs in Resistance to Epidermal Growth Factor Receptor-Targeted Agents and Novel Therapeutic Strategies for Treatment of Non-Small-Cell Lung Cancer. Critical Reviews™ in Oncogenesis. 18(4). 317–326. 10 indexed citations
20.
Avan, Amir, Viola Caretti, Niccola Funel, et al.. (2013). Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met–driven Pancreatic Carcinoma. Cancer Research. 73(22). 6745–6756. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Longjuan Zhang Breakdown of academic impact, for papers by Leina Ma Breakdown of academic impact, for papers by Juanjuan Shan Breakdown of academic impact, for papers by Jiong Bi Breakdown of academic impact, for papers by Ximing Xu Breakdown of academic impact, for papers by Federica Papaccio Breakdown of academic impact, for papers by Keqiang Zhang Breakdown of academic impact, for papers by Limei Liu Breakdown of academic impact, for papers by Xian Lin
Rankless by CCL
2026